The Drug Report

SAM & FDPS
  • 4.6 (33)
  • POLITICS
  • UPDATED WEEKLY
The Drug Report

Expert drug policy news and analysis brought to you by the leading drug policy organizations, Smart Approaches to Marijuana (SAM) and The Foundation for Drug Policy Solutions (FDPS).

  1. JUL 10

    SNEAK PEEK: Kevin Talks About His New Book Here First

    America stands at a crossroads in our battle against addiction, facing the deadliest drug crisis in our nation’s history. With over 100,000 overdose deaths annually, the devastation is undeniable—but so are the solutions. In this special episode, you’ll get an exclusive first look into Kevin’s groundbreaking new book, One Nation Under the Influence. Kevin reveals how proven prevention strategies could slash regular drug use by two-thirds and highlights innovative criminal justice programs like Hawaii’s Project HOPE, which has successfully reduced methamphetamine use by 70%. He explores lessons from America’s dramatic reduction in cigarette smoking and Portugal’s compassionate yet accountable drug policy, illustrating how strategic public policies, social shifts, and accountability can transform addiction outcomes. This episode tackles the harmful false dichotomies holding back progress—treatment vs. harm reduction, criminalization vs. legalization, moral failing vs. medical condition—and demonstrates how embracing comprehensive, evidence-based strategies can create real change. The solutions exist; what’s needed now is the courage to implement them. Join us for this critical conversation about how America can finally turn the tide against addiction. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    26 min

  2. MAR 18

    What's Next in U.S. Drug Policy?

    Drug policy in America is at a critical inflection point. Following a period dominated by extreme harm reduction approaches, we're witnessing a significant shift back toward accountability-based treatment models. This transformation comes as cities like San Francisco and states like Oregon roll back failed experiments that provided tools for addiction without addressing its root causes. Dr. Kevin Sabet joins us fresh from United Nations meetings in Vienna, where American representation was noticeably diminished – a symptom of the current administration's still-developing drug policy strategy. Together, we analyze Dr. Nora Volkow's recent Stat News interview, where the longtime NIDA Director expressed skepticism about universalizing 12-step approaches despite compelling research supporting their effectiveness. As Sabet points out, studies from leading institutions demonstrate that 12-step programs often outperform traditional psychotherapy while lowering healthcare costs. The encouraging decline in opioid overdose deaths presents a complex puzzle we attempt to unravel. Is it increased naloxone availability? Greater public awareness of fentanyl dangers? The tragic reality that many vulnerable users have already died? The answer likely combines these factors, highlighting why comprehensive approaches that blend harm reduction tools with accountability-focused recovery pathways remain essential. As America recalibrates its drug policy strategy, this conversation offers crucial context for understanding what works, what doesn't, and why the pendulum is swinging back toward treatment models that emphasize personal responsibility alongside compassionate care. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    13 min

  3. FEB 27

    Interview with Dr. Robert Marbut about his upcoming film, "Fentanyl: Death Incorporated"

    The fentanyl crisis represents one of America's most pressing public health emergencies, one that has affected countless families and communities across the country. In this engaging episode with Dr. Robert Marbut, we explore the alarming statistics surrounding fentanyl's impact, which has become a leading cause of death, eclipsing even the toll from warfare. Dr. Marbut, a distinguished expert on homelessness and addiction, unpacks the connection between structural issues like mental health and substance use, shedding light on the intricacies of these intertwined crises.  Throughout our conversation, we delve into how societal factors such as loneliness and consumer culture contribute to higher rates of fentanyl use and addiction. Dr. Marbut emphasizes the importance of reclaiming family dynamics in the fight against addiction, noting that two-thirds of the experts pointed to the need for strengthening family bonds as a crucial step toward alleviating these issues.  Listeners gain unique insights into the making of the documentary “Fentanyl: Death Incorporated,” which aims to bring these discussions to a broader audience. Dr. Marbutt shares behind-the-scenes anecdotes that underscore the power of storytelling as a means to foster empathy and inspire action.  This episode isn't just about statistics; it's an urgent call to consider how we can collectively change our response to the crisis. By fostering a culture of connection, understanding, and accountability, we stand a better chance against this existential threat. Join us in this important discussion and explore how you can be part of the solution.  Subscribe for more insightful discussions on drug policy, community action, and strategies to tackle addiction head-on. Don’t forget to leave a review and share this episode with someone who can help raise awareness. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    35 min

  4. JAN 28

    New York OCM Celebrating Marijuana Profits, New York Times Stories

    High THC cannabis products are under intense scrutiny, and with good reason. Kevin Sabet, CEO of SAM Smart Approaches to Marijuana, joins us to dissect the cannabis industry's parallels with big tobacco, especially concerning unproven health claims and the relentless drive for profit. We examine a noteworthy New York Times article and question whether New York's $1 billion in cannabis sales is worth the potential cost to public health. Our discussion focuses on prioritizing health over profit, learning from the tobacco industry's past mistakes, and the crucial role of effective regulation in safeguarding public health.  Our global audience is at the heart of what we do, and your support is invaluable. We are grateful to Kevin for his insights and extend our appreciation to listeners across dozens of countries and countless cities. We're excited to continue bringing you the most pressing news and updates, and we encourage you to share our podcast with others who care about the future of drug policy and public health. If our conversations resonate with you, please leave us a five-star review and share your thoughts as we strive to spark change and meaningful dialogue. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    14 min

  5. JAN 15

    Drug Policy News & Policy Outlook for New Congress

    Can relentless advocacy truly shape the future of marijuana legislation? Join us on the Drug Report podcast as we explore the recent triumph in New Hampshire, where the unwavering efforts of advocates have led Governor Kelly Ayotte to promise a veto on any future marijuana legalization attempts. This victory shines a light on the power of persistence in the ever-evolving landscape of drug policy. As we navigate through these pivotal changes, we're also dissecting the challenges faced by the marijuana industry in New York, revealing how initial promises of social equity have not been fulfilled, leaving many equity applicants in financial distress. Kevin Sabet's op-ed adds a critical perspective to our discussion, emphasizing the widening gap between wealthy investors and disenfranchised communities. Our conversation takes a crucial turn as we tackle issues surrounding medical marijuana prescriptions, drawing comparisons to the opioid crisis of the 1990s. How can we ensure patient safety when a small group of doctors dominates the recommendation landscape? We're also looking at the ongoing efforts in Florida to legalize marijuana and the strategic legislative initiatives being considered by the new Congress. Randy's resolution serves as a cornerstone in raising awareness about the risks of high-potency THC, reflecting a broader strategic approach to drug policy reform and patient protection. Federal marijuana legalization remains a hot topic, with the complexities of state and federal enforcement at the forefront. We address the urgent need for Congress to empower the DOJ in regulating marijuana sales near schools, while also examining the emerging debate around Delta 8, especially as companies like DoorDash enter the market. The unexpected halt in the marijuana rescheduling process due to an industry-filed motion has opened the door for broader scrutiny and discussion. President Trump's ambiguous remarks about the Safe Banking Act add another layer of uncertainty, as we acknowledge the collaborative efforts of advocates striving to navigate these challenging waters. Join us as we break down these pressing issues and stay informed on the latest developments. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    24 min

  6. 11/06/2024

    Big Wins Against Marijuana: How Local Advocacy Overcame Marijuana Legalization

    Could the defeat of Florida's marijuana legalization measure signal a turning tide in drug policy across America? Despite an avalanche of financial backing and celebrity endorsements, Florida's initiative fell short, leaving many to question the power dynamics at play. Join us as we unpack the surprising outcome, delving into the influential role of grassroots campaigns and bipartisan voices, such as the powerful advocacy from former congresswoman Donna Shalala. Discover how "Don't Let Florida Go to Pot" captured the public's attention and vote, challenging the narrative that financial clout guarantees success in the ballot box. Explore the broader shift in drug policy attitudes nationwide, as marijuana legalization efforts face unexpected setbacks in states like North and South Dakota. These defeats highlight the power of community coalitions and parental advocacy in steering public opinion. With concerns over youth usage and black market proliferation, the narrative that marijuana legalization is an unstoppable force is being rewritten. Celebrate these grassroots victories as we spotlight the relentless efforts of local communities standing up to well-funded legalization campaigns. Look to Massachusetts, where the conversation takes a fascinating turn towards psychedelic legalization in progressive hubs like Boston, Cambridge, and Somerville. Uncover the state's storied connection to psychedelics and the surprising voting patterns that emerged. Meanwhile, in Colorado Springs, a significant ban on marijuana sales underscores a commitment to public health priorities. We acknowledge the unwavering dedication of organizations like SAM and the Foundation for Drug Policy Solutions, whose work has been instrumental in these recent victories, marking a pivotal moment in the fight for sensible drug policies. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    19 min

  7. 10/28/2024

    Global Insights on Drug Policy: Highlights from the Lisbon Addictions Conference

    Discover the complexities of today's drug policy landscape with insights from around the globe. We promise an enlightening journey as Kevin Sabat and I unpack the highlights from the recent Lisbon Addictions Conference. We bring you the latest updates and debates on harm reduction versus legalization, spotlighting data-driven discussions from regions like Oregon and British Columbia. As we shift focus to the United States, uncover the stories behind various drug policy ballot measures, including marijuana legalization efforts in Florida and the Dakotas. The challenges New York faces in its legalization journey serve as a cautionary tale, and we even touch on an intriguing psychedelics measure in Massachusetts, hinting at the evolving dynamics in drug policy. In a special segment, Kevin joins me to highlight the importance of staying informed through resources like newsletters from learnaboutsamorg and thedrugreportorg. We emphasize the value of evidence-based policies and encourage robust discussions among our listeners. Make sure to engage with us by subscribing to these newsletters for the latest updates and leave a review to help amplify the conversation. Tune in for a comprehensive understanding of the forces shaping the future of drug policy around the world. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    10 min

  8. 10/15/2024

    Breaking Down VP Harris' Marijuana Plan

    Is federal marijuana legalization truly a win for Black men, or are there hidden pitfalls? Join us as we take a hard look at Vice President Kamala Harris's proposal, focusing on its goal to dismantle systemic barriers and whether it achieves this when it poses new public health risks. With insightful commentary from Will Jones of SAM, we unravel the intricate dynamics between promising business opportunities and the risks of corporate exploitation in the marijuana industry. By drawing parallels with historical public health challenges like the tobacco industry's impact, we critically question whether this federal move could inadvertently harm the communities it seeks to empower. Follow the work of SAM and FDPS below: https://learnaboutsam.org/ https://gooddrugpolicy.org/ https://thedrugreport.org/ On X: https://twitter.com/learnaboutsam https://twitter.com/GoodDrugPolicy https://twitter.com/KevinSabet https://twitter.com/LukeNiforatos On Facebook: https://www.facebook.com/learnaboutsam

    15 min
See All (55)

4.6
out of 5
33 Ratings

About

Expert drug policy news and analysis brought to you by the leading drug policy organizations, Smart Approaches to Marijuana (SAM) and The Foundation for Drug Policy Solutions (FDPS).

Information

  • Creator
    SAM & FDPS
  • Years Active
    2024 - 2025
  • Episodes
    55
  • Rating
    Clean
  • Copyright
    © 2025 The Drug Report
  • Show Website
    The Drug Report

You Might Also Like

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes, and get the latest updates.
Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada